Home > Cloud PRWire > Creo Medical Group “looking very well” – Proactive Research Analyst

Creo Medical Group “looking very well” – Proactive Research Analyst

–News Direct–

Proactive Research Analyst Daniel Appiah gives the highlights from his latest research note on UK-based medical device company Creo Medical Group PLC (AIM:CREO). Creo recently announced that the medical device company's Speedboat Inject product was used for the first time in an upper gastrointestinal (GI) procedure in Europe, a major milestone for the business. Appiah says Creo is "looking very well" and gives his take on what recent developments are likely to mean for the company's financials.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

[email protected]

View source version on newsdirect.com: https://newsdirect.com/news/creo-medical-group-looking-very-well-proactive-research-analyst-460748290

Creo Medical Group PLC

comtex tracking


Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Sahyadri Times journalist was involved in the writing and production of this article.